Vista Current Coverage

All Healthcare/Biotech Articles

Lilly Paying $8 Billion for Loxo Oncology During JPM2019

JPMorgan Healthcare Conference week brings forth another sizable deal as Lilly (LLY) will commence a tender offer to acquire all outstanding shares of Loxo Oncology (LOXO) for a purchase price of $235.00 per share in cash, or approximately $8.0 billion. Lilly is reported to be...

Pfizer Will Raise US Drug Prices in January

Pfizer (PFE)  is a leading global provider of anti-infective medicines, offering patients access to a diverse portfolio of more than 80 products. Pfizer has announced its plan to increase U.S. prices on 41 of its medicines this January. The company had pulled back its original...

CAR-T Pioneer Dr. Grupp Joins Paris Headquartered Cellectis (CLLS)’s CAB

Cellectis S.A. (Euronext Growth: ALCLS; Nasdaq: CLLS), founded in 1999 and headquartered in Paris, France, is a clinical stage biotechnological company, develops and sells immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer in France. The company operates...